Birzeit Pharmaceuticals Company announced unaudited consolidated preliminary financial results for year ended December 31, 2013. For the period, the company's net profit after taxes reached $5,480,204, compared with a net profit after taxes of $4,785,914 in the audited data for 2012, a net increase of 14.5%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.09 USD | +0.99% | -0.24% | -6.41% |
Feb. 25 | Birzeit Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 09 | What does the Gotham City report say about Grifols? | RE |
1st Jan change | Capi. | |
---|---|---|
-6.41% | 159M | |
+20.59% | 43.92B | |
+24.56% | 23.09B | |
+18.88% | 15.35B | |
+12.89% | 13.61B | |
+45.94% | 12.02B | |
-10.14% | 7B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.07% | 5.6B |
- Stock Market
- Equities
- BPC Stock
- News Birzeit Pharmaceuticals Company
- Birzeit Pharmaceuticals Company Announces Unaudited Consolidated Preliminary Financial Results for Year Ended December 31, 2013